if thats true i hope they revisit that, you cant beat recurring revenue. i would also like them to look at pay per use.
i cant see why Australia needs to be different to the states especially if the tests are covered by Medicare (is it?)
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-62
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $111.2M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.5¢ | $47.99K | 858.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 513413 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 102335 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IPD (ASX) Chart |